Search Results - "Campar, Ana"
-
1
Glycans as Key Checkpoints of T Cell Activity and Function
Published in Frontiers in immunology (27-11-2018)“…The immune system is highly controlled and fine-tuned by glycosylation, through the addition of a diversity of carbohydrates structures (glycans) to virtually…”
Get full text
Journal Article -
2
Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome
Published in European journal of case reports in internal medicine (2023)“…Classical Ehlers-Danlos syndrome (cEDS) is one of the 13 subtypes of Ehlers-Danlos syndrome, which has the major clinical criteria of hyperextensibility skin,…”
Get full text
Journal Article -
3
Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance
Published in Frontiers in immunology (17-04-2023)“…Systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), and Sjögren's syndrome (SS) are heterogeneous autoimmune diseases. Severe manifestations…”
Get full text
Journal Article -
4
Orthostatic hypotension as an unusual presentation of spinal calcium pyrophosphate deposition disease: case report and review of literature
Published in Romanian Journal of Internal Medicine (01-12-2023)“…Calcium pyrophosphate crystal deposition disease (CPPD), also known as pseudogout, with spinal involvement, is associated with clinical manifestations of acute…”
Get full text
Journal Article -
5
Muscle glycome in idiopathic inflammatory myopathies: Impact in IL-6 production and disease prognosis
Published in iScience (21-07-2023)“…Idiopathic inflammatory myopathies (IIM) are a group of chronic autoimmune diseases mainly affecting proximal muscles. Absence of meaningful prognostic factors…”
Get full text
Journal Article -
6
Primary Sjögren's syndrome activity and damage indices comparison
Published in European journal of clinical investigation (01-07-2010)“…Eur J Clin Invest 2010; 40 (7): 636–644 Background Significant differences exist in outcome measures developed to assess patients with primary Sjögren’s…”
Get full text
Journal Article -
7
Effectiveness of Tocilizumab in the Treatment of Fasciitis with Eosinophilia: Two Case Reports
Published in European journal of case reports in internal medicine (02-03-2020)“…Fasciitis with eosinophilia (FE) is a rare connective tissue disease. Due to its rarity, large-scale studies are lacking, which makes its treatment…”
Get full text
Journal Article -
8
Idiopathic inflammatory myopathies – The burden of disease: Cohort analysis focusing on damage and comorbidities
Published in Autoimmunity reviews (01-12-2023)Get full text
Journal Article -
9
Aortic Dissection in a Patient with Novel Frameshift COL5A1 Variant of Classical Ehlers-Danlos Syndrome
Published in European journal of case reports in internal medicine (24-01-2023)“…Classical Ehlers-Danlos syndrome (cEDS) is one of the 13 subtypes of Ehlers-Danlos syndrome, which has the major clinical criteria of hyperextensibility skin,…”
Get full text
Journal Article -
10
Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunity
Published in Science translational medicine (15-03-2023)“…Autoimmune diseases are life-threatening disorders that cause increasing disability over time. Systemic lupus erythematosus (SLE) and other autoimmune diseases…”
Get more information
Journal Article -
11
Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2021)“…Objective Changes in protein glycosylation are a hallmark of immune‐mediated diseases. Glycans are master regulators of the inflammatory response and are…”
Get full text
Journal Article -
12
Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance
Published in Autoimmunity reviews (01-08-2023)“…Vasculitis are a very heterogenous group of systemic autoimmune diseases, affecting large vessels (LVV), small vessels or presenting as a multisystemic…”
Get full text
Journal Article -
13
Refractory disease in Systemic Lupus Erythematosus
Published in Autoimmunity reviews (01-09-2011)“…Abstract There is no definition or guidelines for refractory disease (RD) in Systemic Lupus Erythematosus (SLE). However, new therapies have been tested mainly…”
Get full text
Journal Article -
14
Abnormal Glycosignature of Host Tissue Trigger Pathogenic Recognition Through Gamma Delta T Cells/Il-17a Axis in Autoimmunity
Published in European journal of rheumatology (11-05-2024)Get full text
Journal Article -
15
Abnormal Glycosignature of Host Tissue Trigger Pathogenic Recognition Through Gamma Delta T Cells/Il-17a Axis in Autoimmunity
Published in European journal of rheumatology (01-05-2024)Get full text
Journal Article -
16
Immunoglobulin G4 Related-Disease: A Rare Presentation With Secondary Hypereosinophilic Syndrome and Eosinophilic Ascites
Published in Journal of medical cases (2021)“…Immunoglobulin G4 related-disease (IgG4-RD) is a multisystemic immune-mediated fibroinflammatory disease, with a strong predilection for salivary and lacrimal…”
Get full text
Journal Article -
17
Anti-NMDAr Encephalitis and COVID-19 in a Patient With Systemic pANCA-Vasculitis and Recurrent Varicella Zoster Infection
Published in Neurohospitalist (01-04-2022)“…Introduction There is a complex interplay between systemic autoimmunity, immunosuppression, and infections. Any or all of these can result in neurologic…”
Get full text
Journal Article -
18
Association of severe and therapy-refractory systemic lupus erythematosus and neuromyelitis optica: a management challenge
Published in BMJ case reports (04-06-2018)“…Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disorder. Neuromyelitis optica (NMO) is an infrequent neuroinflammatory disorder, whose…”
Get full text
Journal Article -
19
P117 Rituximab therapy for primary Sjögren’s syndrome – a retrospective single-centre study
Published in Lupus science & medicine (01-03-2020)“…BackgroundThe rationale for B cell depletion therapy with rituximab (RTX) in primary Sjögren’s syndrome (pSS) relies upon the well-established role of B cell…”
Get full text
Journal Article -
20
P116 Outcomes and safety of rituximab use in systemic lupus erythematosus – a single-centre analysis
Published in Lupus science & medicine (01-03-2020)“…Background/PurposeRituximab (RTX) has been used worldwide in moderate to severe Systemic Lupus Erythematosus (SLE), despite failure in clinical trials. We…”
Get full text
Journal Article